TELA Bio Reports Third Quarter 2024 Financial Results

TELA Stock  USD 3.03  0.09  3.06%   
About 55% of Tela Bio's investors are presently thinking to get in. The analysis of overall sentiment of trading Tela Bio stock suggests that some investors are interested at this time. The current market sentiment, together with Tela Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Tela Bio stock news signals to limit their universe of possible portfolio assets.
  
Reiterates 2024 Revenue Guidance and Expects Recently Implemented Operational Efficiency Improvements to Reduce Operating Expenses in 2025MALVERN, Pa., Nov. 07, 2024 -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Reported revenue of 19.0 million in the third quarter, representing g

Read at finance.yahoo.com
Yahoo News
  

Tela Bio Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tela Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tela Bio Fundamental Analysis

We analyze Tela Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tela Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tela Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Tela Bio is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Tela Bio Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tela Bio stock to make a market-neutral strategy. Peer analysis of Tela Bio could also be used in its relative valuation, which is a method of valuing Tela Bio by comparing valuation metrics with similar companies.

Peers

Tela Bio Related Equities

TMDXTransMedics   8.06   
0%
100.0%
DCTHDelcath Systems   5.35   
0%
66.0%
TMCITreace Medical   3.38   
0%
41.0%
AXGNAxogen   3.38   
0%
41.0%
TCMDTactile Systems   3.27   
0%
40.0%
SIBNSi Bone   2.39   
0%
29.0%
CLPTClearpoint Neuro   1.25   
0%
15.0%
VREXVarex Imaging   1.03   
0%
12.0%
RXSTRxsight   0.74   
0%
9.0%
NPCENeuropace   0.49   
0%
6.0%
FNAParagon 28   0.10   
0%
1.0%
CVRXCVRx   0.07   
0%
1.0%
OFIXOrthofix Medical   1.09   
13.0%
0%
SGHTSight Sciences   1.76   
21.0%
0%
KIDSOrthopediatrics Corp   2.01   
24.0%
0%
LUNGPulmonx Corp   2.48   
30.0%
0%

Complementary Tools for Tela Stock analysis

When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world